Company Data
Resverlogix Corp.
Ticker
RVX:CA
Current Price
$0.1025 -2.38%
Market Cap
$29.4M
Price Target
Refer to Report
Volume
25.0K
52wk Range
$0.035 - $0.3
Overview
Resverlogix Corp clinical-stage biotechnology company. The company is developing an advanced epigenetic drug called apabetalone for the treatment of patients with cardiovascular disease, diabetes mellitus, chronic kidney disease, peripheral artery disease, orphan diseases, and neurodegenerative diseases.